Puration Announces Alkame Holdings To Join In EVERx CBD Infused Bottled Water Product Launch At Arnold Sports Festival March 2015
Dallas, TX – February 9, 2017 - InvestorsHub NewsWire - Puration, Inc. (USOTC: PURA) today announced Alkame Holdings, Inc. (USOTC: ALKM) will participate in the official launch of EVERx CBD Infused Bottled Water to be held at the Annual Arnold Sports Festival (formerly the Arnold Classic) in Columbus, Ohio starting March 2nd, 2017 and continuing through March 3rd. PURA combines its proprietary CBD with ALKM’s patented alkaline water. Representatives of both companies will be on hand to present the EVERx CBD Infused Bottled Water and answer questions.
EVERx is a new sports, fitness and wellness nutritional supplement brand specializing in products infused with cannabidiol (CBD). The EVERx brand was launched by, and is owned by North American Cannabis Holdings (USOTC: USMJ). PURA licensed from USMJ the rights to develop and market a CBD infused water. EVERx CBD Infused Bottled Water is the first EVERx brand commercial launch.
Named for Arnold Schwarzenegger, The Arnold is host to over 70 sporting events with 18,000 athletes. The Arnold will include an Expo with over 1,000 booths. EVERx CBD Infused Bottled Water can be found at the Arnold in the City BlendsTM VIP Suite. In addition to serving EVERx CBD Infused Water, City BlendsTM Smoothies blended with EVERx CBD Infused Water will also be available.
To learn more about the EVERx CBD Infused Water product launch at the Arnold Sports Festival, follow the link below:
EVERx CBD INFUSED WATER LAUNCH AT THE ARNOLD SPORTS FESTIVAL
To learn more about North American Cannabis Holdings: growusmj.com.
Follow the Company on Twitter: US_HEMP
To learn more about Puration: purationinc.com
Follow Puration on Twitter: Puration710
Visit Puration on Facebook: Facebook.com/puration/
To learn more about Alamke Holdings, Inc.: alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
North American Cannabis Holdings Contact:
Brian Shibley, CEO